Category: Investing

The S&P 500, representing approximately 80% of the U.S. equity market capitalization, is primarily used as a benchmark for investment performance. It is used as a tool by many.

In 2022, over $25 billion in biopharmaceutical exports were from majority foreign-owned firms operating in the United States, highlighting the significant role international investment plays in the industry. This multifaceted financial landscape reveals that answering the question of who owns US pharma is far from straightforward, involving a mix of institutional, public, foreign, and venture capital ownership.